Top Qs
Timeline
Chat
Perspective

2017 DR109

Micro-asteroid classified as near-Earth object of the Apollo group and Aten group From Wikipedia, the free encyclopedia

Remove ads

2017 DR109, is a micro-asteroid, classified as near-Earth object of the Apollo group and Aten group, respectively. It is currently trapped in a 1:1 mean motion resonance with the Earth of the horseshoe type.[5] The object was first observed on 27 February 2017, by astronomers of the Catalina Sky Survey conducted at Mount Lemmon Observatory, Arizona, United States.[2]

Quick Facts Discovery, Discovered by ...
Remove ads

Discovery

2017 DR109 was first observed by astronomer D. C. Fuls on 27 February 2017, using the 0.68-meter Schmidt camera of the Catalina Sky Survey at a visual apparent magnitude of 19.6.[5]:6

Orbit and physical properties

The asteroid's orbit has still a high uncertainty; with a very short observation arc of just 5 days. It orbits the Sun at a distance of 0.76–1.24 AU once every 366 days (semi-major axis of 1.00 AU). Its orbit has an eccentricity of 0.24 and an inclination of 3° with respect to the ecliptic.[1] With a semi-major axis of that of Earth, the object is both classified as a member of Apollo and Aten in the JPL Small-Body Database and by the Minor Planet Center, respectively.[1][2] Both Apollo and Aten asteroids are Earth-crossing asteroids.

Earth co-orbital

2017 DR109 is currently trapped in a 1:1 mean motion resonance with the Earth of the horseshoe type and follows an orbit similar to those of 54509 YORP, 2017 FZ2 and several other near-Earth asteroids.[5]

Remove ads

Physical characteristics

2017 DR109 has an absolute magnitude of 27.6 which gives a calculated mean diameter between 9 and 20 meters for an assumed geometric albedo of 0.20 and 0.04, respectively, which are typical values for stony S-type and carbonaceous C-type asteroids.[3][4]

Notes

  • ^ This is assuming an albedo of 0.20 and 0.04, respectively.

References

Loading related searches...

Wikiwand - on

Seamless Wikipedia browsing. On steroids.

Remove ads